The makers of Xarelto today agreed to pay $775 million in a global settlement to resolve claims by nearly 25,000 plaintiffs nationwide who alleged the popular blood thinner caused serious bleeding episodes.The amount will be paid equally by the two companies, Bayer and Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. As structured, the settlement resolves all pending lawsuits in the U.S. over Xarelto, including about 2,000 in Pennsylvania.
In the suits, plaintiffs claimed Xarelto caused uncontrollable and irreversible bleeding leading to severe injuries such as strokes and even death. Plaintiffs also alleged that the makers never warned of the dangerous risks associated with the drug, and that their injuries could have been prevented if they were made fully aware of potential side effects.
Ross Feller Casey, among the nation’s top personal injury law firms, is representing about 250 people from across the U.S. in cases involving Xarelto.
Disclaimer: Ross Feller Casey, LLP provides legal advice only after an attorney-client relationship is formed. Our website is an introduction to the firm and does not create a relationship between our attorneys and clients. An attorney-client relationship is formed only after a written agreement is signed by the client and the firm. Because every case is unique, the description of awards and summary of cases successfully handled are not intended to imply or guarantee that same success in other cases. Ross Feller Casey, LLP represents catastrophically injured persons and their families in injury and wrongful death cases, providing legal representation in Pennsylvania and New Jersey.